匯友生命科學(08088.HK)擬出售普通合夥人股權,促成合夥企業自美國公司撤資
格隆匯5月26日丨匯友生命科學(08088.HK)宣佈,於2020年5月26日,公司間接全資附屬New Earn擬以現金27萬美元向第三方出售AID Partners Autonomous GP Ltd全部股權,所得款項淨額約150萬港元將用作集團一般營運資金。
AID Partners Autonomous GP Ltd為合夥企業的普通合夥人。合夥企業的主要業務活動為投資控股,其唯一資產為於美國公司股票投資。美國公司Zoox, Inc主要透過其附屬公司從事機械人、領先無人駕駛交通業務。
公司一向之業務策略為因應巿況作出適當的業務決策並對其業務計劃進行最佳調整,儘可能為集團及公司股東創造最佳價值。於2015年,公司發行本金額為1.4億港元、複合年利率為8釐且到期日為2020年7月20日之可換股債券。出售事項乃集團自美國公司撤資的部份程序,原因為其價值自集團於2016年購入以來有所升值,並旨在償還可換股債券以及為集團業務營運及發展提供資金。
買方為其最終實益擁有人Asher Dory於薩摩亞註冊成立作為投資工具的公司。監於Asher Dory專攻新技術方面,並在新興市場電信、資訊科技及金融技術領域的多間知名跨國公司累積豐富經驗,董事會認為,買方可有效促成合夥企業自美國公司撤資。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.